Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients.
Rossi S, Tatangelo V, Dichiara M, Butini S, Gemma S, Brogi S, Pasquini S, Cappello M, Vincenzi F, Varani K, Lopresti L, Malchiodi M, Carrara C, Gozzetti A, Bocchia M, Marotta G, Patrussi L, Carullo G, Baldari CT, Campiani G. Rossi S, et al. Among authors: bocchia m. Biomed Pharmacother. 2024 May;174:116537. doi: 10.1016/j.biopha.2024.116537. Epub 2024 Apr 4. Biomed Pharmacother. 2024. PMID: 38579402 Free article.
A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis.
Vanni F, Lopresti L, Zurli V, Kabanova A, Cattaneo F, Sicuranza A, Gozzetti A, Gemma S, Zisterer DM, Bocchia M, Campiani G, Baldari CT, Butini S, Ulivieri C. Vanni F, et al. Among authors: bocchia m. Pharmacol Res. 2021 Dec;174:105965. doi: 10.1016/j.phrs.2021.105965. Epub 2021 Oct 31. Pharmacol Res. 2021. PMID: 34732370
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia.
Boncompagni G, Tatangelo V, Lopresti L, Ulivieri C, Capitani N, Tangredi C, Finetti F, Marotta G, Frezzato F, Visentin A, Ciofini S, Gozzetti A, Bocchia M, Calzada-Fraile D, Martin Cofreces NB, Trentin L, Patrussi L, Baldari CT. Boncompagni G, et al. Among authors: bocchia m. Cell Death Dis. 2024 Feb 15;15(2):144. doi: 10.1038/s41419-024-06528-6. Cell Death Dis. 2024. PMID: 38360867 Free PMC article.
Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia.
Gozzetti A, Candi V, Brambilla CZ, Papini G, Fabbri A, Bocchia M. Gozzetti A, et al. Among authors: bocchia m. Anticancer Agents Med Chem. 2017;17(8):1040-1045. doi: 10.2174/1871520616666160928153342. Anticancer Agents Med Chem. 2017. PMID: 27697038 Review.
Steps towards a Multiple Myeloma Cure?
Gozzetti A, Bocchia M. Gozzetti A, et al. Among authors: bocchia m. J Pers Med. 2022 Sep 3;12(9):1451. doi: 10.3390/jpm12091451. J Pers Med. 2022. PMID: 36143236 Free PMC article.
Cutaneous myeloma and bortezomib.
Gozzetti A, Defina M, Bocchia M. Gozzetti A, et al. Among authors: bocchia m. Ann Hematol. 2009 Oct;88(10):1045. doi: 10.1007/s00277-009-0786-7. Epub 2009 Jul 14. Ann Hematol. 2009. PMID: 19597817 Free article. No abstract available.
Treatment of smoldering multiple myeloma.
Gozzetti A, Defina M, Bocchia M. Gozzetti A, et al. Among authors: bocchia m. Nat Rev Clin Oncol. 2013 Dec;10(12):724. doi: 10.1038/nrclinonc.2013.160-c1. Epub 2013 Nov 19. Nat Rev Clin Oncol. 2013. PMID: 24247163 No abstract available.
Central nervous system multiple myeloma.
Gozzetti A, Cerase A, Bocchia M. Gozzetti A, et al. Among authors: bocchia m. Ann Hematol. 2016 Feb;95(3):519-20. doi: 10.1007/s00277-015-2586-6. Epub 2016 Jan 8. Ann Hematol. 2016. PMID: 26742499 No abstract available.
317 results